Medical News
August 7th, 2009
The Southern Australian biotech company: Vaxine Pty. Ltd., will be the first to administer a human swine flu vaccine immunization.
August 7th, 2009
Antiretroviral drugs are proving to be safe and helpful, thanks to an international study that examined HIV transmission prevention between mother and child by way of breast milk.
August 7th, 2009
Two Australian biotech companies have began inoculating adult volunteers in the world’s first H1N1 swine flu vaccine trials. Adelaide - based Vaxine initiated trials Monday with 300 participants, and the Melbourne based 7 month CSL study, has 240 participants. According to the Australian Associated Press, there has been at least 41 Aussie deaths.
August 7th, 2009
The US FDA is dedicated to fraudulent enforcement with regards to illegal online product marketing claiming to prevent, diagnose, treat and cure the 2009 H1N1 flu virus.
August 6th, 2009
The US FDA has reported seasonal influenza vaccine approval for 2009 and 2010.
August 6th, 2009
Yoga has become a mainstream, widespread form of physical activity in North America. Just as any other physical activity, precaution must be taken, and you must practice and prepare yourself before engaging in this physical recreation.
August 6th, 2009
Human Genome Sciences and GlaxoSmithKline, recently announced impressive results from their yearlong clinical trial for lupus treatment Benlysta
August 6th, 2009
The US FDA has officially announced their approval to market Onsolis, an advanced treatment used for the management of breakthrough pain, for cancer patients over the age of eighteen, who already receive and have built a tolerance to opiod therapy for unrelenting cancer pain
August 6th, 2009
The US FDA recently announced that it will demand that some immunosuppressant drug manufacturers used in kidney (renal) transplants update their labels to disclose a increased risk of infection
August 6th, 2009
The US FDA is to conduct a safety review of asthma treatment drug Xolair. Xolair is a drug primarily used to treat adults and adolescents who suffer from moderate-to-severe persistent asthma.
